Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 2.
Tax on Rich, Levies Stir Health Debate
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Senate health bill does without a new surtax on the wealthy that House Democrats' legislation includes, but Senate Democrats have their own taxes that are stirring controversy.
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Medtronic Chairman and CEO Bill Hawkins Provides Statement on U.S. Senate's Revised Medical Device Industry Fee ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Applauds Leadership of Sens. Dianne Feinstein and Barbara Boxer, Governor Arnold Schwarzenegger, Representative Anna Eshoo and the California Congressional Delegation
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO B... DevicesMedtronic
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senate's Revised Medical Device Industry Fee ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Applauds Leadership of Senators Amy Klobuchar and Al Franken, Governor Tim Pawlenty and the Minnesota Congressional Delegation
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO Bill Hawkins today issued the following s... DevicesMedtronic
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Statement by Medtronic Chairman and CEO Bill Hawkins Regarding U.S. Senate's Revised Medical Device Industry Fee ProposalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Company Applauds Leadership of Senator Evan Bayh and the Indiana Delegation
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ), chairman and CEO Bill Hawkins today issued the following statement regarding the U.S. Senates revised proposal regar... DevicesMedtronic
Source: HSMN NewsFeed - November 20, 2009 Category: Pharmaceuticals Source Type: news
Tax on Rich, Levies Stir Health DebateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Senate health bill does without a new surtax on the wealthy that House Democrats' legislation includes, but Senate Democrats have their own taxes that are stirring controversy.
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Philip Morris ordered to pay $300m to smokerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A Florida jury orders cigarette maker Philip Morris USA to pay $300m in damages to a 61-year-old ex-smoker who is wheelchair-bound by emphysema
Source: FT.com - Drugs and Healthcare - November 20, 2009 Category: Pharmaceuticals Source Type: news
Group Clarifies Mammograph AdviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The task force that loosened breast-cancer screening guidelines this week clarified its position, in response to the intense backlash its new recommendations have prompted.
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Cheap does not mean cheerful, says Toys R UsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This year's hard-to-find Christmas toy in the US, the Zhu Zhu Pets robotic hamster, costs about $10. But as he flips through Toys R Us's annual catalogue at the...
Source: FT.com - Drugs and Healthcare - November 20, 2009 Category: Pharmaceuticals Source Type: news
Under-fives get swine flu jabsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Children under five will be the next group to be given priority in receiving the swine flu vaccine, Sir Liam Donaldson, the chief medical officer, said yesterday. The...
Source: FT.com - Drugs and Healthcare - November 20, 2009 Category: Pharmaceuticals Source Type: news
Democrats Pitch Health Bill to VotersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Senate Democrats touted the immediate benefits their health bill would bring to Americans, aware that the cost and reach of the bill may already be turning off some voters ahead of the 2010 elections.
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Business Sours on Health OverhaulEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Chances of business supporting the Obama administration's health overhaul are fading fast, after Senate Majority Leader Reid's bill took a liberal turn.
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Group Clarifies Mammography AdviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The task force that loosened breast-cancer screening guidelines this week clarified its position, in response to the intense backlash its new recommendations have prompted.
Source: WSJ.com: Health - November 20, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Almac Doubles Capacity at North Carolina FacilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Almac group has completed a 67,000ft² expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics divisions. Almac Clinical Services first began occupancy of the additional building on the campus in February 2008 and have since added a 30,000ft² warehouse complete with two new loading docks. Staff from Almac Diagnostics' nearby facility in Durham have relocated to the site and are engaged in research activity across a wide-range of projects.
This expansion has greatly increased storage capacity for clinical supplies with a...
Source: Drug Development Technology - November 20, 2009 Category: Pharmaceuticals Source Type: info
85% of Online Europeans Use the Internet for Health InformationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In 2009, 85% of online Europeans in the United Kingdom, Germany, France, Italy, and Spain turn to the Internet and other technologies for health and prescription drug information, according to the latest Cybercitizen Health® Europe v9.0 study from healthcare and pharmaceutical market research company Manhattan Research. The collaboratively-edited Wikipedia again proves to be a top online health resource for consumers in all of the countries surveyed.
Source: World Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler®Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) reduces exacerbations (worsening of symptoms) in patients with chronic obstructive pulmonary disease (COPD).
Source: World Pharma News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Merck Receives CHMP Positive Opinion for New Fertility Treatment,ELONVA®Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Merck.com - Research & Development News - November 20, 2009 Category: Pharmaceuticals Source Type: news
Mammogram Debate Shows Why Reform Will FailEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Why can't we control costs? Because experts who write perfectly reasonable guidelines get branded death panels.
Source: Forbes.com Healthcare News - November 19, 2009 Category: Pharmaceuticals Source Type: news
MAKO Surgical Corp. to Present at the 21st Annual Piper Jaffray Health Care ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FT. LAUDERDALE, Fla., Nov. 19, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the 21st Annual Piper Jaffray Health Care Conference at The New York Palace in New York on Tuesday, December 1, 2009 at 3:30 pm EST.
Source: Medical News (via PRIMEZONE) - November 19, 2009 Category: Pharmaceuticals Source Type: news
Alphatec Spine to Present at the Piper Jaffray 21st Annual Health Care ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CARLSBAD, Calif., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it will present at the Piper Jaffray 21st Annual Health Care Conference on Tuesday, December 1, 2009 at 2:30 p.m. Eastern Time at The New York Palace Hotel, New York, New York.
Source: Medical News (via PRIMEZONE) - November 19, 2009 Category: Pharmaceuticals Source Type: news
Analogic Corporation Announces Timing for First Quarter Fiscal 2010 Earnings Conference CallEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PEABODY, Mass., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG) announced today that it will conduct a conference call on Wednesday, December 9, 2009, at 5:00 p.m. (EST) to discuss results for the first quarter ended October 31, 2009. The conference call will include Jim Green, president and CEO, and Michael Levitz, vice president, chief financial officer, and treasurer. Brief presentations by management will be followed by a question-and-answer session.
Source: Medical News (via PRIMEZONE) - November 19, 2009 Category: Pharmaceuticals Source Type: news
Triangle Capital Corporation Invests $8.0 Million in Anesthesia Services ProviderEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RALEIGH, N.C., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (NASDAQ: TCAP) ("Triangle" or the "Company"), a leading specialty finance company that provides customized financing solutions to lower middle market companies located throughout the United States, today announced that it closed an $8.0 million debt investment with warrants in a leading physician management company that provides contracted outsourced anesthesiology services to hospitals and medical centers in the Midwest.
Source: Medical News (via PRIMEZONE) - November 19, 2009 Category: Pharmaceuticals Source Type: news
FDA Panel Backs Safety, Benefits of SpirivaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
WASHINGTON-Federal health experts on Thursday brushed off
lingering safety questions about a popular inhaler drug and
suggested it carry bolder benefit claims.
The Food and Drug Administration's panel of...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
HealthPort Postpones Initial Public OfferingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ALPHARETTA, Ga., Nov. 19, 2009 (GLOBE NEWSWIRE) -- HealthPort, a top-25 company in the healthcare information technology industry, today announced that it is postponing its planned initial public offering of shares of its Common Stock due to market conditions.
Source: Medical News (via PRIMEZONE) - November 19, 2009 Category: Pharmaceuticals Source Type: news
Health Care Payment Reform: Considerations for Global Payments in MedicaidEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Payment reform is an integral part of national and state-based health reform efforts. Indeed, payment reform is essential to moving from quantity-based reimbursement to a performance-based health care system. That is, moving from fee-for-service to fee-for-value. Payment innovations, such as global payment, are designed to reward efficiency and higher quality, while supporting providers as they invest in patient-centered models...
Source: Piper Report on Health Care - November 19, 2009 Category: Pharmaceuticals Tags: Health Care Policy Source Type: info
BIO Announces Presidents Bill Clinton And George W. Bush To Provide Keynote At 2010 BIO International ConventionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Biotechnology Industry Organization (BIO) announces that Presidents Bill Clinton and George W. Bush, the 42nd and 43rd Presidents of the United States, will appear together for a moderated discussion at the 2010 BIO International Convention, which will be held May 3-6 in Chicago, Ill. at McCormick Place. Presidents Clinton and Bush, who served in the White House for 16 years, will discuss a wide variety of issues relating to both domestic and foreign policy.
Source: Pharma Industry News From Medical News Today - November 19, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
Military Study Shows Prevention of Novel A/H1N1 Virus Infection is Vaccine-Type and Age-DependentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Both Live, Attenuated Influenza Vaccine (LAIV) and Trivalent
Inactivated Vaccine (TIV) provide Protection against novel A/H1N1,
especially against severe disease
WASHINGTON, Nov. 19 /PRNewswire/ -- Immunization with either
live attenuated influenza...
Source: Drugs.com - Clinical Trials - November 19, 2009 Category: Pharmaceuticals Source Type: clinical trials
Positive Results from Chronic Study with Bayer ?s Rivaroxaban Will be Presented As a Late Breaker at ASH 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Positive Results from Chronic Study with Bayer’s
Rivaroxaban Will be Presented As a Late Breaker at ASH 2009
Endpoints met in EINSTEIN-Extension Trial in the Secondary
Prevention of Recurrent Symptomatic VTE
Berlin, November 19, 2009 -...
Source: Drugs.com - Clinical Trials - November 19, 2009 Category: Pharmaceuticals Source Type: clinical trials
Health Sciences Group Quest to be Listed on the OTCBBEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIAN HARBOUR BEACH, Fla., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Health Sciences Group, Inc. (Pink Sheets:HESG) would like to announce that its lawyer Mr. Robert Young is aggressively seeking realtors in the Los Angeles area to open up Health Sciences offices. The company intends on pursuing with new consultant agreement under Marijuana Inc. a joint venture to market management services. "We are still in negotiations with Marijuana Inc. (MJNA) to complete a joint venture or merger or rolling up into a reporting OTCBB shell. We have all intentions of bringing on the best legal team possible and to make medical marijuana accept...
Source: Medical News (via PRIMEZONE) - November 19, 2009 Category: Pharmaceuticals Source Type: news
FDA Issues 22 Warning Letters to Web Site OperatorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: PharmaManufacturing.com - November 19, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
ObamaCare: A Glimmer Of Hope For Cost ControlEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Senate's tax on Cadillac plans could save billions.
Source: Forbes.com Healthcare News - November 19, 2009 Category: Pharmaceuticals Source Type: news
WHO: Swine Flu Shot Not Causing DeathsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
GENEVA--The World Health Organization on Thursday ruled out
swine flu vaccine as the cause of death in 41 people who had
received the flu shot.
WHO vaccines chief Marie-Paule Kieny said deaths...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
FDA Issues 22 Warning Letters to Web Site OperatorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Part of International Internet Week of Action
SILVER SPRING, Md., Nov. 19 /PRNewswire-USNewswire/ --The U.S.
Food and Drug Administration today completed a coordinated,
weeklong, international effort, called the International Internet
Week of...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Indian pharmaceutical market is over Rs 55,000 crEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Indian pharmaceutical market, which has registered robust growth in last few years, was valued at over Rs 55,000 crore in the last fiscal, the Lok Sabha was informed today.
Source: The Economic Times Healthcare and Biotech News - November 19, 2009 Category: Pharmaceuticals Source Type: news
PhRMA Statement on Misleading Reports About Price GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Washington, November 18, 2009 — Pharmaceutical Research
and Manufacturers of America(PhRMA) Senior Vice President Ken
Johnson issued the following statement today:
“It’s pretty obvious that the calls to hold...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Time to Blow Up the Pharmaceutical Sales Model? New Deloitte DebateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
What: "New Commercial Model: Science or Swag?"
Who: W. Scott Evangelista, principal, Deloitte Consulting LLP
When: Available immediately
Where: www.deloitte.com/us/debates/scienceorswag
NEW YORK, Nov. 19 /PRNewswire/ -- Details:...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
General Pharmaceutical Services in England 1999-2000 to 2008-09Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SummaryThis publication shows information about services provided by community pharmacies in England in contract with Primary Care Trusts (PCTs) to di...
Source: The IC : Pharmacies - November 19, 2009 Category: Pharmaceuticals Source Type: organizations
Healthcare Solutions Joins VIIAD Health TicketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Healthcare Solutions, the parent company of Procura Management and Cypress Care, announced today that it has contracted with VIIAD Systems to enable the company to offer VIIAD’s Health Ticket as a service offering to its customers. (PRWeb Nov 19, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3232234.htm
Source: PRWeb: Medical Pharmaceuticals - November 19, 2009 Category: Pharmaceuticals Source Type: news
ADK Information Services, Saint Louis University Launch New Product Safety Information GuideEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
First of its kind directory helps product safety officials locate information and service provider resources to assist in company product safety or recall programs. Directory available in both hard copy and on-line versions. (PRWeb Nov 19, 2009)
Read the full story at http://www.prweb.com/releases/productsafety/productrecalls/prweb3209834.htm
Source: PRWeb: Medical Pharmaceuticals - November 19, 2009 Category: Pharmaceuticals Source Type: news
Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolveEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs. (PRWeb Nov 19, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3223754.htm
Source: PRWeb: Medical Pharmaceuticals - November 19, 2009 Category: Pharmaceuticals Source Type: news
Opinionmeter Releases New HIPPA Compliant SurveyManager for its Healthcare Customer’s Patient Satisfaction SurveysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In collaboration with its healthcare customers, Opinionmeter has recently enhanced its web-based SurveyManager application to include additional HIPPA compliant security requirements, along with many new training and survey related features. (PRWeb Nov 19, 2009)
Read the full story at http://www.prweb.com/releases/patient-feedback/customer-surveys/prweb3230734.htm
Source: PRWeb: Medical Pharmaceuticals - November 19, 2009 Category: Pharmaceuticals Source Type: news
Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional ActivityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Promega Corporation and SwitchGear Genomics announce a novel method for characterizing DNA-protein interactions. (PRWeb Nov 18, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3216534.htm
Source: PRWeb: Medical Pharmaceuticals - November 19, 2009 Category: Pharmaceuticals Source Type: news
Committee Leaders Call for GAO Analysis of Recent Prescription Drug Price IncreasesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON, Nov. 18, 2009--Leaders of the House Ways and Means
and Energy and Commerce Committees sent a letter to the Government
Accountability Office (GAO) last night requesting an expedited
report on recent trends in prescription drug...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Affymax plans to raise $69.6M in stock saleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Biopharmaceutical company Affymax Inc. said Thursday it plans to offer about 4 million shares of its common stock to raise $69.6 million. (AFFY)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 19, 2009 Category: Pharmaceuticals Source Type: journals
FDA Panel Backs Pfizer's Enhanced Vaccine for KidsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
BETHESDA, Md.--Federal health experts said Wednesday an updated
version of Pfizer's best-selling anti-infection vaccine is safe and
effective for infants and toddlers, despite company studies that
failed to...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 ("swine flu") virus.
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Unilife Medical Solutions: Unilife Appoints Unifill(TM) Automated Assembly Line SupplierEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEWISBERRY, PA (MARKET WIRE) Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI)(PINKSHEETS: UNIFF) today announced the appointment of Mikron Group ("Mikron") as its contracted supply partner for the development and supply of automated assembly systems to support the commercial production of the Unifill(TM) ready-to-fill syringe (Unifill(TM) syringe).
Source: Market Wire - Pharmaceuticals and Biotech - November 19, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Manufacturing and Production UNI UNIFF Source Type: news
AstraZeneca Seeks Brilinta Approval in USEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 19, 2009)
LONDON–AstraZeneca PLC said Thursday it has applied to
U.S. regulators to market its blood clot preventer Brilinta, a
potential new big seller for the company.
AstraZeneca submitted a new drug...
Source: Drugs.com - Pharma News - November 19, 2009 Category: Pharmaceuticals Source Type: news
Scancell Selects PharmaNet Development Group For SCIB1 Clinical TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scancell Holdings Plc, (PLUS:SCLP), the parent company of Scancell Limited ('Scancell'), the developer of innovative therapeutic cancer vaccines, is pleased to announce that it expects to commence its Phase I/II clinical trial with SCIB in the first half of 2010.
Source: Pharmaceutical Online News - November 19, 2009 Category: Pharmaceuticals Source Type: news
VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect ProfileEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Results Underscore Differentiating Profile; Indicate
Significant Market Opportunity for Avanafil
MOUNTAIN VIEW, Calif., Nov. 18 /PRNewswire-FirstCall/ -- VIVUS,
Inc. (NASDAQ:VVUS) today announced positive results
from REVIVE (TA-301), a phase 3...
Source: Drugs.com - Clinical Trials - November 19, 2009 Category: Pharmaceuticals Source Type: clinical trials
